Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
机构：[1]Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, Chengdu, China四川省肿瘤医院[2]Department of Radiochemotherapy Oncology, Sichuan Provincial Cancer Hospital, Chengdu, China四川省肿瘤医院[3]Department of Radiotherapy, Sichuan Cancer Hospital, Chengdu, China四川省肿瘤医院
Lv Jiahua,Li Tao,Deng Xiaorong,et al.Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.[J].JOURNAL OF CLINICAL ONCOLOGY.2015,33(15):doi:10.1200/jco.2015.33.15_suppl.4035.
APA：
Lv, Jiahua,Li, Tao,Deng, Xiaorong,Li, Fang,Song, Yanqiong...&Wang, Junchao.(2015).Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma..JOURNAL OF CLINICAL ONCOLOGY,33,(15)
MLA：
Lv, Jiahua,et al."Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.".JOURNAL OF CLINICAL ONCOLOGY 33..15(2015)
医学